AstraZeneca (AZN) said it is investing $50 billion in U.S. manufacturing by 2030, following the lead of big pharma peers that have, combined, announced more than $200 billion in investments in coming ...

April 9: Trump's higher "reciprocal tariffs" begin just after midnight. Hours later, the president says he is issuing a 90-day pause on those duties, except for China. Trump raises tariffs on Chinese ...

President Trump’s threat to impose 30% tariffs on the European Union disrupted negotiations. From cars to wine, these are the ...

President Donald Trump has threatened tariffs on drugs coming from overseas, but it might take more than that to reroute the ...

Amidst this market environment, the portfolio underperformed the Russell Midcap® Growth Index in the second quarter.

President Richard Nixon’s launch of the War on Drugs in the early 1970s marked a turning point in U.S. drug policy. By ...

Investors were braced for further developments on U.S trade policy following reports that Trump was pushing for minimum tariffs of 15% to 20% on imports from the EU. Member states, meanwhile, were ...

U.S. stocks moved higher on Monday as optimism around earnings overshadowed any investor fears over the latest developments ...

Pharmaceutical manufacturing in the U.S. has declined sharply over recent decades, with most active ingredient production shifting overseas due to lower labor costs. In 2023, the U.S.

The Supreme Court has decided not to expedite a legal challenge concerning tariffs imposed by President Donald Trump. This ruling has left many companies, particularly those in the toy industry, ...

Despite former President Donald Trump’s threat of a 200% tariff on imported drugs during a cabinet meeting, pharmaceutical investors have shown surprisingly positive sentiment this week. Despite ...

U.S. President Donald Trump’s new Africa strategy shifts from aid to trade under a “commercial diplomacy” push, urging ...